LLM Job #16363 - score_story_relevance
Conversation
You are a financial news analyst. Rate news stories based on their relevance to serious business and investment decision-making.
Rate this news story's relevance for investors and business professionals who manage investment portfolios and need to make informed decisions. This is ONE news story covered by MULTIPLE news sources. The titles below are from different outlets (Reuters, Bloomberg, CNBC, etc.) all reporting on the SAME business event. Rate the overall story's relevance. Article Titles: 1. FDA instability, alarm over agency’s direction escalate after top regulator exits 2. Biotech presses on as FDA reshuffles 3. FDA appoints Tracy Hoeg as acting director of drug evaluation center 4. 'Unprecedented turmoil' engulfing FDA threatens public health: mRNA coalition speaks out Scoring Guidelines: - 9-10: Critical business news (earnings reports, Fed decisions, major M&A, sector-wide impact, regulatory changes) - 7-8: Important analysis (market trends, analyst insights, significant company developments, economic indicators) - 5-6: Relevant news (notable company announcements, industry developments, financial performance) - 3-4: Minor business news (routine updates, small moves, tangential business stories) - 1-2: Fluff/entertainment (celebrity CEO drama, viral marketing, cultural controversies, consumer complaints) High-value examples: - "Wall Street Sentiment on AI Companies Shifts as Earnings Disappoint" (9-10) - "Federal Reserve Minutes Reveal Concerns About Inflation Persistence" (9-10) - "Apple Supplier Cuts Production by 20% Amid Weak iPhone Demand" (8-9) - "Banking Sector Faces Regulatory Scrutiny After Failed Stress Tests" (8-9) Low-value examples: - "Starbucks Cup Design Sparks Outrage on Social Media" (1-2) - "CEO's Dog Makes Appearance at Company Event" (1-2) - "Company Changes Office Snack Selection" (1-2)
{
"explanation": "This news story centers on leadership instability and organizational turmoil at the U.S. Food and Drug Administration (FDA), a critical regulatory body for the pharmaceutical and biotechnology sectors. The departure of a top regulator, the appointment of an acting director, and public warnings from industry coalitions about threats to public health and regulatory continuity signal significant uncertainty. For investors and business professionals managing portfolios—especially in healthcare, biotech, and pharmaceuticals—this represents a high-impact regulatory development. Regulatory stability directly affects drug approval timelines, clinical trial funding, market entry strategies, and investment risk in life sciences. The potential for delayed approvals, increased regulatory scrutiny, or policy shifts due to leadership instability can significantly influence valuation and risk assessments. The fact that multiple reputable outlets (Reuters, Bloomberg, CNBC) report on the same event underscores its importance. The mention of 'unprecedented turmoil' and a coalition speaking out further emphasizes systemic concern. This is not routine administrative change—it reflects potential long-term implications for innovation, investment, and market dynamics in a heavily regulated industry.\n\nTherefore, this story falls in the 9–10 range: critical business news with sector-wide implications, regulatory impact, and material influence on investment decisions in healthcare and biotech sectors.",
"score": 9
}Debug Information
▶ Structured Output Schema (JSON Schema)
{
"json_schema": {
"description": "Business relevance score for a news story",
"name": "story_relevance",
"schema": {
"additionalProperties": false,
"properties": {
"explanation": {
"description": "1-2 sentence explanation of the score",
"type": "string"
},
"score": {
"description": "Relevance score (1-10)",
"maximum": 10,
"minimum": 1,
"type": "integer"
}
},
"required": [
"score",
"explanation"
],
"type": "object"
},
"strict": true
},
"type": "json_schema"
}▶ Token Usage & Performance
{
"completion_tokens": 266,
"predicted_ms": 0,
"prompt_ms": 0,
"prompt_tokens": 429,
"total_tokens": 695
}▶ Context & Parameters (Full JSON)
{
"article_count": 4,
"explanation": "This news story centers on leadership instability and organizational turmoil at the U.S. Food and Drug Administration (FDA), a critical regulatory body for the pharmaceutical and biotechnology sectors. The departure of a top regulator, the appointment of an acting director, and public warnings from industry coalitions about threats to public health and regulatory continuity signal significant uncertainty. For investors and business professionals managing portfolios—especially in healthcare, biotech, and pharmaceuticals—this represents a high-impact regulatory development. Regulatory stability directly affects drug approval timelines, clinical trial funding, market entry strategies, and investment risk in life sciences. The potential for delayed approvals, increased regulatory scrutiny, or policy shifts due to leadership instability can significantly influence valuation and risk assessments. The fact that multiple reputable outlets (Reuters, Bloomberg, CNBC) report on the same event underscores its importance. The mention of 'unprecedented turmoil' and a coalition speaking out further emphasizes systemic concern. This is not routine administrative change—it reflects potential long-term implications for innovation, investment, and market dynamics in a heavily regulated industry.\n\nTherefore, this story falls in the 9–10 range: critical business news with sector-wide implications, regulatory impact, and material influence on investment decisions in healthcare and biotech sectors.",
"finish_reason": "stop",
"google_story_id": 23173,
"max_tokens": 2000,
"relevance_score": 9,
"response_format": "json_schema",
"response_format_details": {
"json_schema": {
"description": "Business relevance score for a news story",
"name": "story_relevance",
"schema": {
"additionalProperties": false,
"properties": {
"explanation": {
"description": "1-2 sentence explanation of the score",
"type": "string"
},
"score": {
"description": "Relevance score (1-10)",
"maximum": 10,
"minimum": 1,
"type": "integer"
}
},
"required": [
"score",
"explanation"
],
"type": "object"
},
"strict": true
},
"type": "json_schema"
},
"temperature": 0
}